CME Group Price Target Raised to $68.00 at JPMorgan Chase & Co. (CME)
Equities researchers at JPMorgan Chase & Co. boosted their target price on shares of CME Group (NYSE:CME) from $67.50 to $68.00 in a research report issued on Tuesday. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s target price suggests a potential downside of 4.29% from the stock’s previous close.
Shares of CME Group (NYSE:CME) traded down 1.51% during mid-day trading on Tuesday, hitting $71.05. The stock had a trading volume of 1,346,311 shares. CME Group has a 1-year low of $66.44 and a 1-year high of $84.71. The stock’s 50-day moving average is $71.06 and its 200-day moving average is $73.20. The company has a market cap of $23.858 billion and a price-to-earnings ratio of 24.05.
CME Group (NYSE:CME) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.83 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.83. The company had revenue of $777.00 million for the quarter, compared to the consensus estimate of $368.13 million. During the same quarter in the prior year, the company posted $0.73 earnings per share. The company’s quarterly revenue was up 8.1% on a year-over-year basis. Analysts expect that CME Group will post $3.28 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Barclays raised their price target on shares of CME Group from $75.00 to $77.00 in a research note on Monday, June 30th. They now have an “equal weight” rating on the stock. Separately, analysts at Zacks downgraded shares of CME Group from a “neutral” rating to an “underperform” rating in a research note on Monday, June 9th. They now have a $63.00 price target on the stock. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of CME Group in a research note on Friday, May 9th. They now have a $84.00 price target on the stock, down previously from $89.00. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the stock. CME Group currently has a consensus rating of “Hold” and an average target price of $76.00.
CME Group Inc (NYSE:CME) offer a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.